Compare CCEL & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | CLIR |
|---|---|---|
| Founded | 1989 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8M | 33.3M |
| IPO Year | 2022 | 2011 |
| Metric | CCEL | CLIR |
|---|---|---|
| Price | $3.42 | $4.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 7.6K | ★ 15.2K |
| Earning Date | 04-14-2026 | 04-09-2026 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $25,384,279.00 | $530,000.00 |
| Revenue This Year | N/A | $34.29 |
| Revenue Next Year | N/A | $67.31 |
| P/E Ratio | $355.00 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $0.39 |
| 52 Week High | $5.52 | $7.56 |
| Indicator | CCEL | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 47.68 |
| Support Level | $3.18 | $4.18 |
| Resistance Level | $3.57 | $4.75 |
| Average True Range (ATR) | 0.18 | 0.40 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 2.04 | 28.99 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.